libra

looking beyond the joint in RA

LiBRA - Looking Beyond the Joint in RA is Sanofi Genzyme and Regeneron's annual standalone educational program led by a global expert faculty to share thought-provoking, stimulating, and clinically impactful data to assist healthcare professionals in improving RA patient outcomes by achieving better disease control.

The LiBRA program is aligned to Sanofi Genzyme and Regeneron Alliance's commitment to the RA community to improve the treatment, education, and care for RA patients.

Scroll

Scroll down button

OUR CHALLENGE IN RA

Libra 2018

FACULTY INTERVIEWS

Aletaha interview image

Professor Daniel Aletaha

Medical University of Vienna, Austria

The impact of treat to target, collaborative goal setting and the management of comorbidities on outcomes for patients with rheumatoid arthritis

Choy interview image

Professor Ernest Choy

Cardiff University, UK

The role of cytokines in the pathogenesis of rheumatoid arthritis

Gabay interview image

Professor Cem Gabay

University Hospital of Geneva, Switzerland

Biomarkers in rheumatoid arthritis

Poulsen interview image

Professor Thomas Mandrup-Poulsen

University of Copenhagen, Denmark

Metabolic alterations in patients with rheumatoid arthritis

Zoltan interview image

Professor Zoltán Szekanecz

University of Debrecan, Hungary

Multidisciplinary approach to the management of comorbidities in patients with rheumatoid arthritis